Darwin Wealth Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Darwin Wealth Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.48M	Buy	+14,714	New	+$1.51M	0.39%	70

Other funds holding IHE

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Prospera Financial Services Dallas, Texas $7.73B AUM 29.41% 1-Year Est. Return

McElhenny Sheffield Capital Management Dallas, Texas $431M AUM 6.99% 1-Year Est. Return

Arkansas Financial Group Little Rock, Arkansas $751M AUM 9.21% 1-Year Est. Return

Well Done LLC Holland, Michigan $732M AUM 14.62% 1-Year Est. Return

Virtue Capital Management Brentwood, Tennessee $768M AUM 30.82% 1-Year Est. Return

Darwin Wealth Management's IHE Position: Q3 2026 in Review

Darwin Wealth Management opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2026: 14,714 shares worth $1.48M. The stake represents 0.39% of the portfolio and ranks #70 among its holdings.

137 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

Darwin Wealth Management held 14,714 shares of iShares US Pharmaceuticals ETF worth $1.48M as of Q3 2026.
iShares US Pharmaceuticals ETF was a new Darwin Wealth Management position in Q3 2026.
iShares US Pharmaceuticals ETF made up 0.39% of Darwin Wealth Management's portfolio in Q3 2026, its #70 holding.
137 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Darwin Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.